ATE474610T1 - Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen - Google Patents

Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen

Info

Publication number: ATE474610T1
Authority: AT; Austria
Prior art keywords: devices; agents; compounds; medical device; utilized
Prior art date: 2004-03-22

Application number

AT05251712T

Other languages

English (en)

Inventor

Robert Falotico

Tom Jay Parry

Jonathon Z Zhao

Original Assignee

Cordis Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-22

Filing date

2005-03-21

Publication date

2010-08-15

2005-03-21 Application filed by Cordis Corp filed Critical Cordis Corp

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE474610T1 publication Critical patent/ATE474610T1/de

Links

CQOQDQWUFQDJMK-SSTWWWIQSA-N 2-methoxy-17beta-estradiol Chemical compound C([C@@H]12)C[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]1CCC1=C2C=C(OC)C(O)=C1 CQOQDQWUFQDJMK-SSTWWWIQSA-N 0.000 title 1
208000024248 Vascular System injury Diseases 0.000 title 1
208000012339 Vascular injury Diseases 0.000 title 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
229960002930 sirolimus Drugs 0.000 title 1
230000002792 vascular Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 5
150000001875 compounds Chemical class 0.000 abstract 5
229940124597 therapeutic agent Drugs 0.000 abstract 4
229940126585 therapeutic drug Drugs 0.000 abstract 4
239000000560 biocompatible material Substances 0.000 abstract 2
208000007536 Thrombosis Diseases 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000010828 elution Methods 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Materials For Medical Uses (AREA)
Media Introduction/Drainage Providing Device (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Prostheses (AREA)
Surgical Instruments (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT05251712T 2004-03-22 2005-03-21 Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen ATE474610T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/805,736 US7875282B2 (en)	2004-03-22	2004-03-22	Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury

Publications (1)

Publication Number	Publication Date
ATE474610T1 true ATE474610T1 (de)	2010-08-15

Family

ID=34940609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05251712T ATE474610T1 (de)	2004-03-22	2005-03-21	Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen

Country Status (8)

Country	Link
US (1)	US7875282B2 (de)
EP (1)	EP1588725B1 (de)
JP (1)	JP5052757B2 (de)
CN (2)	CN1672746A (de)
AT (1)	ATE474610T1 (de)
CA (1)	CA2499254C (de)
DE (1)	DE602005022378D1 (de)
ES (1)	ES2347443T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7611533B2 (en)	1995-06-07	2009-11-03	Cook Incorporated	Coated implantable medical device
US7419678B2 (en) *	2000-05-12	2008-09-02	Cordis Corporation	Coated medical devices for the prevention and treatment of vascular disease
US8038708B2 (en)	2001-02-05	2011-10-18	Cook Medical Technologies Llc	Implantable device with remodelable material and covering material
US7056338B2 (en)	2003-03-28	2006-06-06	Conor Medsystems, Inc.	Therapeutic agent delivery device with controlled therapeutic agent release rates
CA2503625A1 (en) *	2002-11-13	2004-05-27	Setagon, Inc.	Medical devices having porous layers and methods for making same
US9770349B2 (en) *	2002-11-13	2017-09-26	University Of Virginia Patent Foundation	Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
US20060121080A1 (en) *	2002-11-13	2006-06-08	Lye Whye K	Medical devices having nanoporous layers and methods for making the same
EP1610823B1 (de)	2003-03-28	2011-09-28	Innovational Holdings, LLC	Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
WO2005030091A2 (en) *	2003-09-25	2005-04-07	Scios Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
US8652502B2 (en) *	2003-12-19	2014-02-18	Cordis Corporation	Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
US8747881B2 (en)	2003-12-19	2014-06-10	Cordis Corporation	Intraluminal medical devices in combination with therapeutic agents
US20050249776A1 (en) *	2003-12-19	2005-11-10	Chen Chao C	Coated aneurysmal repair device
US8778014B1 (en)	2004-03-31	2014-07-15	Advanced Cardiovascular Systems, Inc.	Coatings for preventing balloon damage to polymer coated stents
US20050278011A1 (en) *	2004-06-10	2005-12-15	Peckham John E	Stent delivery system
US20060095121A1 (en) *	2004-10-28	2006-05-04	Medtronic Vascular, Inc.	Autologous platelet gel on a stent graft
US20070134163A1 (en)	2005-12-13	2007-06-14	Zhao Jonathon Z	Radiographic contrasting agents and radio-opaque polymeric materials for medical devices
US10029034B2 (en) *	2005-12-15	2018-07-24	CARDINAL HEALTH SWITZERLAND 515 GmbH	Drug-eluting articles with improved drug release profiles
US8617192B2 (en) *	2006-02-22	2013-12-31	Bradley H. Strauss	Guide-wire sleeve for facilitation of lesion crossing
WO2007143433A1 (en) *	2006-05-31	2007-12-13	Setagon, Inc.	Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
US20070298067A1 (en) *	2006-06-22	2007-12-27	Boston Scientific Scimed, Inc.	Control release drug coating for medical devices
CN101007187B (zh) *	2007-01-26	2014-01-01	复旦大学附属华山医院	一种复合药物洗脱支架及其药物涂层的制备方法
US20110137243A1 (en) *	2007-09-06	2011-06-09	Abbott Cardiovascular Systems Inc.	Coating On A Balloon Device
US8048442B1 (en)	2008-09-16	2011-11-01	Abbott Cardiovascular Systems Inc.	Modified heparin-based coatings and related drug eluting stents
US9295663B2 (en)	2010-07-14	2016-03-29	Abbott Cardiovascular Systems Inc.	Drug coated balloon with in-situ formed drug containing microspheres
JP6153133B2 (ja) *	2010-12-15	2017-06-28	コロスパンリミテッドＣｏｌｏｓｐａｎＬｔｄ．	吻合部位をバイパスするためのシステムおよび方法
EP2968730B1 (de)	2013-03-15	2019-01-09	Bitol Designs, LLC	Okklusionsresistenter katheter und verfahren zur verwendung
JP2017535322A (ja)	2014-10-14	2017-11-30	コロスパンリミテッドＣｏｌｏｓｐａｎＬｔｄ．	デバイスを中空器官に送達するための器具
CN113384390B (zh)	2015-09-15	2023-08-22	萨维奇医疗股份有限公司	用于在组织腔中锚定护套的装置和方法
CN111870397B (zh) *	2020-08-30	2024-08-23	吉林大学	基于原位监测的仿生人工瓣膜抗凝性能测试装置
CN113413237A (zh) *	2021-06-01	2021-09-21	温州医科大学	一种具有同心环图案的可降解的药物缓释涂层表面修饰的人工晶状体及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2188277A (en) *	1937-04-24	1940-01-23	Oxweld Acetylene Co	Acetylene generator
US3060877A (en) *	1960-02-23	1962-10-30	Singer Mfg Co	Lubrication system for sewing machine loop taker
ZA737247B (en) *	1972-09-29	1975-04-30	Ayerst Mckenna & Harrison	Rapamycin and process of preparation
US3959078A (en)	1973-05-18	1976-05-25	Midwest Research Institute	Enzyme immobilization with a thermochemical-photochemical bifunctional agent
SU1088712A1 (ru)	1979-11-14	1984-04-30	Всесоюзный научно-исследовательский и испытательный институт медицинской техники	Аппарат дл циркул рного сшивани кровеносных сосудов
US4366819A (en)	1980-11-17	1983-01-04	Kaster Robert L	Anastomotic fitting
US4368736A (en)	1980-11-17	1983-01-18	Kaster Robert L	Anastomotic fitting
SE431609B (sv)	1982-06-24	1984-02-20	Unilink Ab	Kirurgiskt instrument for astadkommande av anastomos och festelement herfor
US4917091A (en)	1982-06-24	1990-04-17	Unilink Ab	Annular fastening means
US4722906A (en)	1982-09-29	1988-02-02	Bio-Metric Systems, Inc.	Binding reagents and methods
US4743327A (en) *	1984-06-15	1988-05-10	Cordis Corporation	Adhesive bonding of fluoropolymers
US4733665C2 (en)	1985-11-07	2002-01-29	Expandable Grafts Partnership	Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5234447A (en)	1990-08-28	1993-08-10	Robert L. Kaster	Side-to-end vascular anastomotic staple apparatus
US5229172A (en)	1993-01-19	1993-07-20	Medtronic, Inc.	Modification of polymeric surface by graft polymerization
US5308641A (en)	1993-01-19	1994-05-03	Medtronic, Inc.	Biocompatibility of solid surfaces
US5350800A (en)	1993-01-19	1994-09-27	Medtronic, Inc.	Method for improving the biocompatibility of solid surfaces
US5837313A (en)	1995-04-19	1998-11-17	Schneider (Usa) Inc	Drug release stent coating process
US6120536A (en)	1995-04-19	2000-09-19	Schneider (Usa) Inc.	Medical devices with long term non-thrombogenic coatings
US6099562A (en)	1996-06-13	2000-08-08	Schneider (Usa) Inc.	Drug coating with topcoat
EP1226796B1 (de)	1997-02-03	2005-06-01	Angioguard, Inc.	Gefässfilter
US6221467B1 (en) *	1997-06-03	2001-04-24	Scimed Life Systems, Inc.	Coating gradient for lubricious coatings on balloon catheters
US6425898B1 (en)	1998-03-13	2002-07-30	Cordis Corporation	Delivery apparatus for a self-expanding stent
US8029561B1 (en)	2000-05-12	2011-10-04	Cordis Corporation	Drug combination useful for prevention of restenosis
US6153252A (en)	1998-06-30	2000-11-28	Ethicon, Inc.	Process for coating stents
US20070032853A1 (en)	2002-03-27	2007-02-08	Hossainy Syed F	40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7419678B2 (en) *	2000-05-12	2008-09-02	Cordis Corporation	Coated medical devices for the prevention and treatment of vascular disease
WO2002087372A1 (en) *	2001-01-10	2002-11-07	Trask David V	Improved snowshoe
US7651695B2 (en) *	2001-05-18	2010-01-26	Advanced Cardiovascular Systems, Inc.	Medicated stents for the treatment of vascular disease
JP4347044B2 (ja)	2001-07-26	2009-10-21	アバンテクバスキュラーコーポレーション	可変放出プロフィールを有する治療用薬剤を送達するための装置
US7195640B2 (en)	2001-09-25	2007-03-27	Cordis Corporation	Coated medical devices for the treatment of vulnerable plaque
US20030065382A1 (en)	2001-10-02	2003-04-03	Fischell Robert E.	Means and method for the treatment of coronary artery obstructions
CN1303947C (zh) *	2001-12-13	2007-03-14	华东理工大学	药物洗脱性心血管支架及其制备方法
WO2003073985A2 (en)	2002-03-01	2003-09-12	Entremed, Inc.	New methods of using antiangiogenic agents
CN1191099C (zh)	2002-04-26	2005-03-02	维科医疗器械(苏州)有限公司	一种药物包被血管支架
CN100471469C (zh) *	2002-06-27	2009-03-25	微创医疗器械(上海)有限公司	一种具有多层涂层的药物洗脱支架

2004
- 2004-03-22 US US10/805,736 patent/US7875282B2/en not_active Expired - Fee Related
2005
- 2005-03-03 CA CA2499254A patent/CA2499254C/en not_active Expired - Lifetime
- 2005-03-18 JP JP2005079900A patent/JP5052757B2/ja not_active Expired - Fee Related
- 2005-03-21 ES ES05251712T patent/ES2347443T3/es not_active Expired - Lifetime
- 2005-03-21 DE DE602005022378T patent/DE602005022378D1/de not_active Expired - Lifetime
- 2005-03-21 AT AT05251712T patent/ATE474610T1/de not_active IP Right Cessation
- 2005-03-21 EP EP05251712A patent/EP1588725B1/de not_active Expired - Lifetime
- 2005-03-22 CN CNA2005100560381A patent/CN1672746A/zh active Pending
- 2005-03-22 CN CN201210495692.2A patent/CN103170012B/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2499254C (en)	2014-01-28
US7875282B2 (en)	2011-01-25
CN103170012A (zh)	2013-06-26
ES2347443T3 (es)	2010-10-29
US20050209688A1 (en)	2005-09-22
CA2499254A1 (en)	2005-09-22
EP1588725A1 (de)	2005-10-26
JP2005270658A (ja)	2005-10-06
CN1672746A (zh)	2005-09-28
CN103170012B (zh)	2016-12-21
JP5052757B2 (ja)	2012-10-17
EP1588725B1 (de)	2010-07-21
DE602005022378D1 (de)	2010-09-02

Legal Events

Date	Code	Title	Description
2011-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE474610T1 (de)	2010-08-15	Lokale, vaskuläre verabreichung von 2- methoxyestradiol in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
ATE442169T1 (de)	2009-09-15	Lokale, vaskuläre verabreichung von cladribin in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
EP2286848A3 (de)	2012-08-29	Lokale vaskuläre Abgabe von Mycophenolsäure in Kombination mit Rapamycin zur Verhinderung von Restenose
EP1582225A3 (de)	2008-06-04	Arzneimittelabgabevorrichtung
EP1568387A3 (de)	2006-01-25	Beschichtung mit strahlenschützender Verbindung für medizinische Geräte
EP1591108A3 (de)	2007-08-29	Formulierungen von Sirolimus und seine Analoge in Lösungsform zur Behandlung von koronaren Herzkrankheit
EP1723976A3 (de)	2011-08-03	Therapeutische Mittel enthaltend intraluminale Instrumente
EP3056229A3 (de)	2016-11-02	Lokale verabreichung einer kombination von rapamycin und 17-beta-estradiol zur behandlung von vulnerabler plaque
CA2490170A1 (en)	2005-06-19	Local vascular delivery of trichostatin a alone or in combination with sirolimus to prevent restenosis following vascular injury
CA2467797A1 (en)	2004-11-20	Increased biocompatibility of implantable medical devices
EP1974758A3 (de)	2010-11-03	Lokale, vaskuläre Versorgung von Probucol allein oder in Kombination mit Sirolimus zur Behandlung der Restenose, empfindlichem Plaque, AAA und Schlaganfall
ATE475438T1 (de)	2010-08-15	Lokale, vaskuläre verabreichung von etoposide in kombination mit rapamycin zur vorbeugung von restenose nach gefässverletzungen
EP1749545A3 (de)	2007-03-21	System zur Behandlung von Aneurysmen
US7906133B2 (en)	2011-03-15	Optimized dosing for drug coated stents
EP2042202A3 (de)	2012-11-21	Lokale vaskuläre Abgabe von mTOR-Inhibitoren in Kombination mit von Peroxisom-Proliferatoren aktivierten Rezeptorstimulatoren
DE60308256D1 (de)	2006-10-26	Beschichtetes medizinsches Implantat zur Behandlung von Gefässerkrankungen
CA2462479A1 (en)	2004-09-30	Modified delivery device for coated medical devices
ATE358505T1 (de)	2007-04-15	Beschichtete endovaskuläre vorrichtung
MXPA03006825A (es)	2004-09-03	Dispositivos vasculares revestidos.
MXPA03003869A (es)	2004-09-06	Dispositivos medicos revestidos.
EP2196226A3 (de)	2010-08-04	Beschichtete medizinische Geräte
DE602005022645D1 (de)	2010-09-16	Implantierbare vaskuläre Vorrichtung zur Abgabe von Topotecan in Kombination mit Rapamycin
EP2095833A3 (de)	2013-09-18	Schichtweise stereo-komplexierte Polymere als Wirkstoffdepotträger oder Beschichtungen in medizinischen Vorrichtungen
AP2003002828A0 (en)	2003-09-30	Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
EP1586338A3 (de)	2008-03-26	Verwendung von Antioxidantien zur Verhinderung von Oxidation und zur Reduzierung von Wirkstoffzersetzung in wirkstoffhaltigen medizinischen Artikeln